Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Rawcliffe Adrian

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 17, 2024Sale$0.6730,08020,24444,848Jan 17, 2024, 05:31 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 16, 2024Sale$0.799,3047,35014,104Jan 17, 2024, 05:31 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 11, 2024Sale$0.8411,9459,99418,395Jan 12, 2024, 05:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 12, 2024Sale$0.8517,25714,73926,388Jan 12, 2024, 05:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerSep 01, 2023Sale$0.782,4031,8743,449Sep 01, 2023, 07:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJun 27, 2023Sale$0.922,3332,1463,519Jun 27, 2023, 09:15 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 17, 2023Sale$1.8610,05718,68613,351Jan 17, 2023, 09:15 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 11, 2023Sale$1.7513,04222,78217,298Jan 12, 2023, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 12, 2023Sale$1.7118,76332,01024,882Jan 12, 2023, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 04, 2023Sale$1.695,0738,5946,631Jan 04, 2023, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerSep 01, 2022Sale$1.972,5364,9933,316Sep 01, 2022, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJun 27, 2022Sale$1.632,5624,1763,290Jun 27, 2022, 09:01 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 18, 2022Sale$3.1911,09635,41612,312Jan 18, 2022, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 11, 2022Sale$3.5614,36251,08115,978Jan 13, 2022, 09:01 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 12, 2022Sale$3.543,04610,7953,356Jan 13, 2022, 09:01 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 04, 2022Sale$4.065,53222,4836,172Jan 05, 2022, 09:04 PM
ADAP]Adaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerSep 01, 2021Sale$5.202,78214,4523,070Sep 01, 2021, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJun 28, 2021Sale$4.372,79412,2103,058Jun 28, 2021, 09:01 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 19, 2021Sale$5.679,87956,00913,529Jan 19, 2021, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 12, 2021Sale$6.152,70716,6543,695Jan 12, 2021, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 04, 2021Sale$5.334,96726,4646,737Jan 05, 2021, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerSep 01, 2020Sale$8.512,77623,6373,076Sep 02, 2020, 09:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerAug 03, 2020Sale$9.252,78825,7893,064Aug 04, 2020, 09:01 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 14, 2020Sale$5.133,23616,6163,166Jan 15, 2020, 08:01 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Executive OfficerJan 06, 2020Sale$1.205,9007,0805,804Jan 07, 2020, 08:00 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Financial OfficerJan 14, 2019Sale$5.373,08416,5593,318Jan 16, 2019, 09:30 PM
ADAPAdaptimmune Therapeutics PLCRawcliffe AdrianChief Financial OfficerMar 20, 2018Sale$1.71600,0001,026,0000Mar 22, 2018, 09:01 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe